跳至主要内容
临床试验/CTRI/2021/08/035450
CTRI/2021/08/035450招募中未知

Concordance study of Circulating Tumor Cells (CTCs) with Biopsy in Patients with newly diagnosed Lung Cancer

Datar Cancer Genetics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Provision of signed dated informed consent form.
  • Suspected to have malignancy or newly diagnosed for lung malignancy(therapy naÃ?¯ve)

排除标准

  • Failure to meet any or all of the above criteria.
  • Positive for HIV, HBV, HCV, or tuberculosis.
  • Received any type or anticancer treatment since diagnosis; includes systemic therapy, radiation or surgery.
  • Received blood transfusion within last 30 days.
  • Underwent PET-CT scan within last 5 days.
  • Unable to undergo tissue biopsy as part of Standard diagnostic Workup.

研究者

相似试验